As of 2025-06-02, the EV/EBITDA ratio of Lumos Pharma Inc (LUMO) is -0.68. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. LUMO's latest enterprise value is 24.02 mil USD. LUMO's TTM EBITDA according to its financial statements is -35.56 mil USD. Dividing these 2 quantities gives us the above LUMO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.1x - 11.5x | 9.8x |
| Forward P/E multiples | 10.6x - 20.1x | 15.4x |
| Fair Price | (42.01) - (45.71) | (50.13) |
| Upside | -1068.0% - -1153.2% | -1255.1% |
| Date | EV/EBITDA |